Q/C Technologies, Inc. Impairment of Intangible Assets (Excluding Goodwill)
Q/C Technologies, Inc. (QCLS) reported Impairment of Intangible Assets (Excluding Goodwill) of $3.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-08-12
- Q/C Technologies, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2026-06-30 was $3.18M.
- Q/C Technologies, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2020-12-31 was $0.00.
- Q/C Technologies, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2020-09-30 was $0.00.
- Q/C Technologies, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2020-06-30 was $149.87K.
- Q/C Technologies, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2020 was $152.82K, a 363.38% increase from fiscal 2019.
- Q/C Technologies, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2019 was $32.98K, a 95.39% decline from fiscal 2018.
- Q/C Technologies, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2018 was $716.15K.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.18M 10-Q · filed 2026-08-12 | $3.18M 10-Q · filed 2026-08-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $149.87K derived: sum of 3 quarters · filed 2021-03-01 | $152.82K 10-K · filed 2021-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $149.87K derived: sum of 2 quarters · filed 2020-11-16 | $152.82K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $149.87K 10-Q · filed 2020-08-14 | $152.82K 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $2.95K 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | $32.98K 10-K · filed 2021-03-01 | |||
| 2018-12-31 | $716.15K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |